国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Cupriavidus pinatubonensis UPF0317 protein Reut_A2449 (Reut_A2449) CSB-YP676202DZR
CSB-EP676202DZR
CSB-BP676202DZR
CSB-MP676202DZR
CSB-EP676202DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis 3-isopropylmalate dehydrogenase (leuB) CSB-YP676203DZR
CSB-EP676203DZR
CSB-BP676203DZR
CSB-MP676203DZR
CSB-EP676203DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Maf-like protein Reut_A2269 (Reut_A2269) CSB-YP676204DZR
CSB-EP676204DZR
CSB-BP676204DZR
CSB-MP676204DZR
CSB-EP676204DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis UvrABC system protein C (uvrC), partial CSB-YP676205DZR
CSB-EP676205DZR
CSB-BP676205DZR
CSB-MP676205DZR
CSB-EP676205DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Translation initiation factor IF-1 1 (infA1) CSB-YP676206DZR
CSB-EP676206DZR
CSB-BP676206DZR
CSB-MP676206DZR
CSB-EP676206DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis 5'-nucleotidase surE (surE) CSB-YP676207DZR
CSB-EP676207DZR
CSB-BP676207DZR
CSB-MP676207DZR
CSB-EP676207DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Protein hfq (hfq) CSB-YP676208DZR
CSB-EP676208DZR
CSB-BP676208DZR
CSB-MP676208DZR
CSB-EP676208DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Translation initiation factor IF-2 (infB), partial CSB-YP676209DZR
CSB-EP676209DZR
CSB-BP676209DZR
CSB-MP676209DZR
CSB-EP676209DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Disulfide bond formation protein B (dsbB), partial CSB-YP676210DZR1
CSB-EP676210DZR1
CSB-BP676210DZR1
CSB-MP676210DZR1
CSB-EP676210DZR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Outer membrane lipoprotein BfpB (bfpB) CSB-YP676211EOB
CSB-EP676211EOB
CSB-BP676211EOB
CSB-MP676211EOB
CSB-EP676211EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Endoglucanase 5 (celV) CSB-YP676212ESP
CSB-EP676212ESP
CSB-BP676212ESP
CSB-MP676212ESP
CSB-EP676212ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Ribosome-recycling factor (frr) CSB-YP676213DZR
CSB-EP676213DZR
CSB-BP676213DZR
CSB-MP676213DZR
CSB-EP676213DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Putative phosphotransferase Reut_A1865 (Reut_A1865) CSB-YP676214DZR
CSB-EP676214DZR
CSB-BP676214DZR
CSB-MP676214DZR
CSB-EP676214DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colicin-A (caa), partial CSB-YP676215ENL1
CSB-EP676215ENL1
CSB-BP676215ENL1
CSB-MP676215ENL1
CSB-EP676215ENL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Acyl-coenzyme A dehydrogenase (fadE), partial CSB-YP676216ENV
CSB-EP676216ENV
CSB-BP676216ENV
CSB-MP676216ENV
CSB-EP676216ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Antitoxin YafN (yafN) CSB-YP676217ENV
CSB-EP676217ENV
CSB-BP676217ENV
CSB-MP676217ENV
CSB-EP676217ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dickeya dadantii Transcriptional activator protein expR (expR) CSB-YP676218DKD
CSB-EP676218DKD
CSB-BP676218DKD
CSB-MP676218DKD
CSB-EP676218DKD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Taurine import ATP-binding protein TauB (tauB) CSB-YP676219DZR
CSB-EP676219DZR
CSB-BP676219DZR
CSB-MP676219DZR
CSB-EP676219DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dickeya dadantii Flavohemoprotein (hmp) CSB-YP676220DKD
CSB-EP676220DKD
CSB-BP676220DKD
CSB-MP676220DKD
CSB-EP676220DKD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Harpin hrpN (hrpN) CSB-YP676221ESP
CSB-EP676221ESP
CSB-BP676221ESP
CSB-MP676221ESP
CSB-EP676221ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>